All of the statistical analyses for this study were performed with SPSS for Windows software package, version 11.5 (SPSS Inc., Chicago, Illinois, USA). A two-tailed P <0.05 was considered statistically significant. The categorical variables are presented as percentage, whereas the continuous data are presented as the mean ± SD. A Chi-square test was performed to evaluate the allelic and genotypic frequencies that were calculated from the observed genotypic counts. Using Chi-square tests for categorical variables and one-way ANOVA for continuous variables, characteristics of subjects were compared between those with or without MetS and between those with or without the -395A allele, respectively. Because the prevalence of MetS was generally higher in women than in men [16 (link)], we reported the results in men and women, respectively, as well as in the whole population. In addition, odds ratios (OR) and 95 % confidential intervals (CI) for MetS were determined using binary logistic regression models.
Spss software package for windows version 11
Manufactured by IBM
Sourced in United States
SPSS software package for Windows, version 11.5, is a data analysis software that provides tools for data management, statistical analysis, and visualization. It is designed to help users effectively analyze and interpret data.
Automatically generated - may contain errors
Lab products found in correlation
5 protocols using spss software package for windows version 11
1
Metabolic Syndrome Genetic Associations
2
Metastatic Tumor miRNA Expression Analysis
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Results are presented as mean±standard deviation for continuous variables, and defined as percentages for categorical variables. We used the Kolmogorov-Smirnov test to assess the distributions of continuous variables. Mann-Whitney nonparametric tests were used to compare the differences in expression levels of miRNAs between different clinicopathologic disease groups such as metastatic and localized tumor groups. Unsupervised hierarchical cluster analysis was also performed to evaluate miRNA expression signatures in different tumor subtypes. All analyses were performed using SPSS for Windows software package, version 11.5 (SPSS Inc., Chicago, USA). All p-values were two-tailed, and p<0.05 was set as the level of statistical significance.
3
Comparative Analysis of Physiological Responses
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The values are expressed as mean ± standard deviation for 6 animals per group. Differences between groups were assessed by one-way analysis of variance using SPSS software package for Windows, version 11.5 (SPSS Inc., Chicago, IL, USA). Post hoc testing was performed for intergroup comparisons using the least significance difference test.
4
Experimental Procedure for Biological Analysis
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Values are expressed as the mean ± standard deviation of three measurements or assessments. Data were analyzed using the SPSS software package for Windows (version 11.5; SPSS, Inc., Chicago, IL, USA). Analysis of differences between groups was performed by one-way analysis of variance. P<0.05 was considered to indicate a statistically significant difference.
5
Evaluating PMD Risk Factors
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The measurement data were analyzed using a univariate analysis with Student's t-test or Chi-square test. Logistic regression analysis was used to evaluate the relationship between PMD and the independent risk factors. All statistical analyses were performed with SPSS software package for Windows version 11.5. (Statistical Product and Service Solutions, Chicago, USA) Data were expressed as the mean ± SEM and statistical significance was set at p<0.05.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!